Polygoni rhizoma inhibits inflammatory response through inactivation of nuclear factor-kappaB and mitogen activated protein kinase signaling pathways in RAW264.7 mouse macrophage cells

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 239-245

  Seo, Hyuk Jin ^a   Huh, Jeong Eun ^a   Han, Jong Hyun ^a   Jeong, Soo Jin ^a   Jang, Jinsil ^a   Lee, Eun Ok ^a   Lee, Hyo Jung ^a   Lee, Hyo Jeong ^a   Ahn, Kyoo Seok ^a   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

antiinflammation; mitogen activated protein kinase; nuclear factor kappaB; Polygoni Rhizoma

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PLANT EXTRACT; POLYGONUM EXTRACT; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL STRAIN RAW264.7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; POLYGONUM; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOME; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; POLYGONUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856264840     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3530     Document Type: Article

References (52)

1. Ajizian SJ, English BK, Meals EA,. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179: 939-944. (Pubitemid 29159340)
2. Altavilla D, Squadrito F, Bitto A, et al,. 2009. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol 157: 1410-1418.
3. Bonizzi G, Karin M,. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288. (Pubitemid 38610351)
4. Bralley EE, Greenspan P, Hargrove JL, Wicker L, Hartle DK,. 2008. Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm (Lond) 5: 1.
5. Burg ND, Pillinger MH,. 2001. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 99: 7-17.
6. Caivano M,. 1998. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 429: 249-253. (Pubitemid 28300369)
7. Carter AB, Knudtson KL, Monick MM, Hunninghake GW,. 1999. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 274: 30858-30863.
8. Chang JS, Liu HW, Wang KC, et al,. 2005. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res 66: 29-34.
9. Chen D, Nie M, Fan MW, Bian Z,. 2008. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology 82: 264-269.
10. D'Acquisto F, May MJ, Ghosh S,. 2002. Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv 2: 22-35.
11. De Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA,. 1997. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol 273: G1290-G1296.
12. Dinarello CA,. 2000. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11: 483-486.
13. Feng L, Zhang LF, Yan T, Jin J, Tao WY,. 2006. [ Studies on active substance of anticancer effect in Polygonum cuspidatum ]. Zhong Yao Cai 29: 689-691.
14. Fujiwara N, Kobayashi K,. 2005. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4: 281-286. (Pubitemid 40873112)
15. Geng JG,. 2001. Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies. Cell Res 11: 85-88. (Pubitemid 33677212)
16. Ghanim H, Sia CL, Abuaysheh S, et al,. 2010. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 95: E1-E8.
17. Guzik TJ, Korbut R, Adamek-Guzik T,. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469-487. (Pubitemid 38029745)
18. Han J, Lee JD, Bibbs L, Ulevitch RJ,. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811. (Pubitemid 24266145)
19. Hippisley-Cox J, Coupland C,. 2005. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Br Med J 330: 1366.
20. Huerre MR, Gounon P,. 1996. Inflammation: patterns and new concepts. Res Immunol 147: 417-434. (Pubitemid 27045862)
21. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL,. 2007. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46: 108-125. (Pubitemid 46661865)
22. Kidd BL,. 2006. Osteoarthritis and joint pain. Pain 123: 6-9. (Pubitemid 43816779)
23. Kim YW, Zhao RJ, Park SJ, et al,. 2008. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 154: 165-173. (Pubitemid 351620405)
24. Kleinert H, Schwarz PM, Forstermann U,. 2003. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-1364. (Pubitemid 37508640)
25. Kumar A, Dhawan S, Aggarwal BB,. 1998. Emodin (3-methyl-1,6,8- trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17: 913-918. (Pubitemid 28430214)
26. Lappas M, Permezel M, Georgiou HM, Rice GE,. 2002. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67: 668-673. (Pubitemid 34803959)
27. Lenzer J,. 2005. FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. Br Med J 330: 440.
28. Li Q, Verma IM,. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
29. Lim BO, Lee JH, Ko NY, et al,. 2007. Polygoni cuspidati radix inhibits the activation of Syk kinase in mast cells for antiallergic activity. Exp Biol Med (Maywood) 232: 1425-1431.
30. Liu SF, Malik AB,. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645. (Pubitemid 43738989)
31. Liu ZP, Li WX, Yu B, et al,. 2005. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food 8: 14-19. (Pubitemid 40617031)
32. Manna SK, Mukhopadhyay A, Aggarwal BB,. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519. (Pubitemid 30408836)
33. Manthey CL, Wang SW, Kinney SD, Yao Z,. 1998. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64: 409-417. (Pubitemid 28409249)
34. Moncada S, Palmer RM, Higgs EA,. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
35. Nagy G, Clark JM, Buzas EI, Gorman CL, Cope AP,. 2007. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 111: 1-5. (Pubitemid 47017476)
36. Nakano H, Shindo M, Sakon S, et al,. 1998. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 95: 3537-3542.
37. Nathan C,. 2002. Points of control in inflammation. Nature 420: 846-852. (Pubitemid 36019637)
38. O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N,. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 273: 30410-30414. (Pubitemid 28545513)
39. Pope RM, Tschopp J,. 2007. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56: 3183-3188. (Pubitemid 47585412)
40. Pratico D, Dogne JM,. 2005. Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine. Circulation 112: 1073-1079. (Pubitemid 41170276)
41. Rankin JA,. 2004. Biological mediators of acute inflammation. AACN Clin Issues 15: 3-17.
42. Roth J, Storr B, Voigt K, Zeisberger E,. 1998. Inhibition of nitric oxide synthase attenuates lipopolysaccharide-induced fever without reduction of circulating cytokines in guinea-pigs. Pflugers Arch 436: 858-862.
43. Saag KG,. 1997. Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence. Am J Med 103: 31S-39S. (Pubitemid 28073158)
44. Shapiro L, Dinarello CA,. 1995. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92: 12230-12234. (Pubitemid 26014044)
45. Shin EM, Zhou HY, Guo LY, et al,. 2008. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol 8: 1524-1532.
46. Song JH, Kim SK, Chang KW, Han SK, Yi HK, Jeon JG,. 2006. In vitro inhibitory effects of Polygonum cuspidatum on bacterial viability and virulence factors of Streptococcus mutans and Streptococcus sobrinus. Arch Oral Biol 51: 1131-1140.
47. Surh YJ, Chun KS, Cha HH, et al,. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481: 243-268.
48. Tegeder I, Geisslinger G,. 2006. Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmiedebergs Arch Pharmacol 373: 1-17.
49. Tripathi P, Kashyap L, Singh V,. 2007. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol 51: 443-452. (Pubitemid 350076162)
50. Vanden Berghe W, Plaisance S, Boone E, et al,. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273: 3285-3290. (Pubitemid 28109741)
51. Yamaoka S, Courtois G, Bessia C, et al,. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93: 1231-1240. (Pubitemid 28307427)
52. Yan J, Greer JM,. 2008. NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS Neurol Disord Drug Targets 7: 536-557.